Literature DB >> 35536703

Functional Imaging of Neuroendocrine Tumors: Stacking the Odds in a Patient's Favor.

Karel Pacak1, David Taieb2, Abhishek Jha1.   

Abstract

Entities:  

Keywords:  functional imaging; neuroendocrine tumor; paraganglioma; pheochromocytoma

Mesh：

Year:  2022        PMID： 35536703      PMCID： PMC9387716          DOI： 10.1210/clinem/dgac298

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   6.134


× No keyword cloud information.
  8 in total

1.  Imaging of Small Intestine Neuroendocrine Neoplasms: Is SSTR PET the Holy Grail?

Authors:  Alessio Imperiale; Leah Meuter; Karel Pacak; David Taïeb
Journal:  J Nucl Med       Date:  2021-03-26       Impact factor: 10.057

2.  First-in-Human Experience With 177Lu-DOTAGA.(SA.FAPi)2 Therapy in an Uncommon Case of Aggressive Medullary Thyroid Carcinoma Clinically Mimicking as Anaplastic Thyroid Cancer.

Authors:  Sanjana Ballal; Madhav Prasad Yadav; Euy Sung Moon; Frank Rösch; Sreedharan Thankarajan ArunRaj; Shipra Agarwal; Madhavi Tripathi; Ranjit Kumar Sahoo; Chandrasekhar Bal
Journal:  Clin Nucl Med       Date:  2022-04-04       Impact factor: 7.794

Review 3.  Molecular Imaging of Neuroendocrine Neoplasms.

Authors:  Julie Refardt; Johannes Hofland; Damian Wild; Emanuel Christ
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

4.  Improving Contrast and Detectability: Imaging with [55Co]Co-DOTATATE in Comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATE.

Authors:  Thomas L Andersen; Christina Baun; Birgitte B Olsen; Johan H Dam; Helge Thisgaard
Journal:  J Nucl Med       Date:  2019-09-13       Impact factor: 10.057

5.  Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.

Authors:  Francesca Borgna; Stephanie Haller; Josep M Monné Rodriguez; Mihaela Ginj; Pascal V Grundler; Jan Rijn Zeevaart; Ulli Köster; Roger Schibli; Nicholas P van der Meulen; Cristina Müller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-08       Impact factor: 9.236

6.  Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.

Authors:  Dominik Berzaczy; Chiara Giraudo; Alexander R Haug; Markus Raderer; Daniela Senn; Georgios Karanikas; Michael Weber; Marius E Mayerhoefer
Journal:  Clin Nucl Med       Date:  2017-09       Impact factor: 7.794

7.  Diagnostic Value of Seven Different Imaging Modalities for Patients with Neuroblastic Tumors: A Network Meta-Analysis.

Authors:  Yu Wang; Yanfeng Xu; Ying Kan; Wei Wang; Jigang Yang
Journal:  Contrast Media Mol Imaging       Date:  2021-09-01       Impact factor: 3.161

Review 8.  High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Neeta Pandit-Taskar; Karel Pacak; Abhishek Jha; David Taïeb; Jorge A Carrasquillo; Daniel A Pryma; Mayank Patel; Corina Millo; Wouter W de Herder; Jaydira Del Rivero; Joakim Crona; Barry L Shulkin; Irene Virgolini; Alice P Chen; Bhagwant R Mittal; Sandip Basu; Joseph S Dillon; Thomas A Hope; Carina Mari Aparici; Andrei H Iagaru; Rodney J Hicks; Anca M Avram; Jonathan R Strosberg; Ali Cahid Civelek; Frank I Lin
Journal:  Clin Cancer Res       Date:  2021-03-08       Impact factor: 13.801
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.